en
Scientific article
Open access
English

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)

Published inAnnals of oncology, vol. 11, no. 3, p. 301-306
Publication date2000
Abstract

A multi-centric trial was performed to explore the clinical activity, in terms of response and toxicity (primary objectives), duration of response and survival (secondary objectives), of docetaxel with cisplatin in advanced gastric cancer (AGC).

eng
Keywords
  • Adenocarcinoma/drug therapy/mortality/secondary
  • Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
  • Cisplatin/administration & dosage/adverse effects
  • Humans
  • Paclitaxel/administration & dosage/adverse effects/analogs & derivatives
  • Stomach Neoplasms/drug therapy/mortality/pathology
  • Survival Analysis
  • Taxoids
NoteOpen Access - Licence nationale Oxford University Press
Citation (ISO format)
ROTH, Arnaud et al. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). In: Annals of oncology, 2000, vol. 11, n° 3, p. 301–306. doi: 10.1023/A:1008342013224
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0923-7534
386views
136downloads

Technical informations

Creation04/08/2015 4:43:00 PM
First validation04/08/2015 4:43:00 PM
Update time11/23/2023 8:58:04 AM
Status update11/23/2023 8:58:04 AM
Last indexation11/23/2023 8:58:07 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack